The store will not work correctly when cookies are disabled.
6-[(4-(Methylthio)benzyl)thio]-9H-purine
ID: ALA4778242
PubChem CID: 146314022
Max Phase: Preclinical
Molecular Formula: C13H12N4S2
Molecular Weight: 288.40
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CSc1ccc(CSc2ncnc3[nH]cnc23)cc1
Standard InChI: InChI=1S/C13H12N4S2/c1-18-10-4-2-9(3-5-10)6-19-13-11-12(15-7-14-11)16-8-17-13/h2-5,7-8H,6H2,1H3,(H,14,15,16,17)
Standard InChI Key: CKQGHSFGJJURHZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
42.8475 -12.3197 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.8463 -13.1393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.5544 -13.5482 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
43.5526 -11.9109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.2612 -12.3161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.2660 -13.1348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.0460 -13.3832 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
45.5234 -12.7181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.0383 -12.0587 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
43.5501 -11.0937 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
42.8412 -10.6872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.1347 -11.0979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4296 -10.6906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7236 -11.1006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7256 -11.9187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4395 -12.3250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.1426 -11.9126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.0196 -12.3303 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
39.3102 -11.9248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
4 10 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
15 18 1 0
18 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 288.40 | Molecular Weight (Monoisotopic): 288.0503 | AlogP: 3.37 | #Rotatable Bonds: 4 |
Polar Surface Area: 54.46 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.91 | CX Basic pKa: 3.54 | CX LogP: 3.18 | CX LogD: 3.17 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.59 | Np Likeness Score: -1.54 |
References
1. Rojas-Prats E,Martinez-Gonzalez L,Gonzalo-Consuegra C,Liachko NF,Perez C,Ramírez D,Kraemer BC,Martin-Requero Á,Perez DI,Gil C,de Lago E,Martinez A. (2021) Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral sclerosis., 210 [PMID:33139113] [10.1016/j.ejmech.2020.112968] |